Australian Regulator Raises Antitrust Concerns Over Zoetis' Acquisition of Neogen's Animal Genomics Business
The Australian Competition and Consumer Commission has raised antitrust concerns regarding Zoetis’ $160 million acquisition of Neogen’s animal genomics business, prompting a call for an in-depth review. The deal could face regulatory hurdles due to potential market concentration issues.
Topics: acquisition merger regulation